COVID-19 Outcome Prediction Algorithm
NCT05471011
COVID-19, Chronic Disease
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT07071142
This study aims to investigate the prevalence of frailty and its association with six-month clinical outcomes in elderly patients with heart failure and left ventricular ejection fraction greater than 40%. Elderly patients diagnosed with heart failure will be assessed for frailty status and followed up for six months to evaluate outcomes such as hospitalization and mortality. The study is observational and will help improve understanding of the impact of frailty on the prognosis of heart failure patients with ejection fraction >40%.
This study is active but is not currently recruiting participants.
Notify Me60 year and older
All sexes
Observational
Thong Nhat Hospital - Cardiology Outpatient Clinic, Ho Chi Minh City, Ho Chi Minh, Vietnam
This observational cohort study aims to evaluate the prevalence of frailty and its association with six-month clinical outcomes, including hospitalization and mortality, in elderly patients with heart failure (HF) and left ventricular ejection fraction (LVEF) >40%.
The study is conducted at the Cardiology outpatient clinics of Thong Nhat Hospital and the Heart Failure Clinic of the University Medical Center, Ho Chi Minh City, Vietnam. A total of approximately 301 patients aged ≥60 years with HF and LVEF >40% (per ESC 2021 criteria) will be enrolled. Baseline assessments include demographic and clinical characteristics, geriatric syndromes, and laboratory findings. Frailty will be assessed using Fried criteria; functional status using Katz ADL and Lawton IADL; nutritional status using the Mini Nutritional Assessment (MNA); depression using the Geriatric Depression Scale-15 (GDS-15); and polypharmacy, comorbidities, and falls will also be recorded.
Participants will be followed for six months to collect data on hospitalizations, mortality, and other adverse clinical outcomes. Data collection will be performed by trained investigators using standardized case report forms (CRFs) and entered into a secure electronic database. Data will undergo regular quality checks for accuracy, completeness, and consistency, with predefined range and logic checks, and source data verification against medical records for a random sample of participants.
Standard Operating Procedures (SOPs) are implemented to ensure uniformity in patient recruitment, informed consent, data collection, follow-up, and adverse event reporting. A data dictionary describing all variables, coding schemes, and normal reference ranges has been developed and will be maintained. Missing data will be documented and addressed using appropriate imputation or sensitivity analyses as outlined in the statistical analysis plan (SAP).
The sample size of approximately 301 participants is based on an expected frailty prevalence of ~50% in this population, allowing estimation with acceptable precision and adequate power to detect associations with outcomes. Statistical analyses will include descriptive statistics, Kaplan-Meier survival analysis, and multivariable regression modeling to assess the relationship between frailty and clinical outcomes while adjusting for potential confounders.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months after enrollment
The number of participants who experience any of the following within 6 months after enrollment: all-cause mortality, cardiovascular mortality, all-cause hospitalization, or hospitalization for heart failure. The composite outcome includes either death or hospitalization from any cause. Events are verified from medical records and caregiver interviews.
Duyen Nguyen Hoang Mai
Other
Frailty and 6-Month Clinical Outcomes in Elderly Patients With Heart Failure and Left Ventricular Ejection Fraction >40%
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05471011
COVID-19, Chronic Disease
Los Angeles, California, United States
View Trial DetailsNCT07180147
Alzheimer Disease, Alzheimer Disease (AD)
Arlington, Virginia, United States
View Trial DetailsNCT07258615
Age-Related Frailty, Frailty
Pozuelo de Alarcón, Madrid, Spain
View Trial DetailsNCT06470308
Chemically-Induced Disorders, Deprescriptions
Heraklion, Heraklion, Crete, Greece
View Trial Details